March 3, 2026 · Form 4 insider transaction
Poole Jonathan bought 7,482 shares of ACADIA Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 17 days after the transaction.
The shares subject to the stock option will vest in equal annual installments over three years following the date of grant such that the stock option will be fully vested on the third anniversary of the date of grant.